Journal Menu
► ▼ Journal Menu-
- Pharmaceuticals Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
28 April 2025
Pharmaceuticals | Top 5 Selected Papers Published in 2024 in the Section “Biopharmaceuticals”
We invite you to explore the following top five papers published in 2024 in the “Biopharmaceuticals” Section:
1. “Microbial Biosurfactants: Antimicrobial Activity and Potential Biomedical and Therapeutic Exploits”
by Patricia Puyol McKenna, Patrick J. Naughton, James S. G. Dooley, Nigel G. Ternan, Patrick Lemoine and Ibrahim M. Banat
Pharmaceuticals 2024, 17(1), 138; https://doi.org/10.3390/ph17010138
Available online: https://www.mdpi.com/1424-8247/17/1/138
2. “A Comprehensive Review of Silver and Gold Nanoparticles as Effective Antibacterial Agents”
by Ricardo Aguilar-Garay, Luis F. Lara-Ortiz, Maximiliano Campos-López, Dafne E. Gonzalez-Rodriguez, Margoth M. Gamboa-Lugo, Jorge A. Mendoza-Pérez, Álvaro Anzueto-Ríos and Dulce E. Nicolás-Álvarez
Pharmaceuticals 2024, 17(9), 1134; https://doi.org/10.3390/ph17091134
Available online: https://www.mdpi.com/1424-8247/17/9/1134
3. “Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression”
by João Panão Costa, Armando de Carvalho, Artur Paiva and Olga Borges
Pharmaceuticals 2024, 17(7), 964; https://doi.org/10.3390/ph17070964
Available online: https://www.mdpi.com/1424-8247/17/7/964
4. “A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide”
by Steliana Tsouri, Evanthia Tselo, Georgios E. Premetis, Veronika Furlan, Panagiota D. Pantiora, Barbara Mavroidi, Dimitris Matiadis, Maria Pelecanou, Anastassios C. Papageorgiou, Urban Bren et al.
Pharmaceuticals 2024, 17(3), 365; https://doi.org/10.3390/ph17030365
Available online: https://www.mdpi.com/1424-8247/17/3/365
5. “Potential of DPD ((S)-4,5-dihydroxy-2,3-pentanedione) Analogs in Microparticulate Formulation as Vaccine Adjuvants”
by Devyani Joshi, Sarthak Shah, Christiane Chbib and Mohammad N. Uddin
Pharmaceuticals 2024, 17(2), 184; https://doi.org/10.3390/ph17020184
Available online: https://www.mdpi.com/1424-8247/17/2/184
